Aims: High-density lipoprotein (HDL) contains multiple components that endow it with biological activities. Apolipoprotein A-I (apoA-I) and surface phospholipids contribute to these activities; however, structure-function relationships in HDL particles remain incompletely characterized.
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Materials and Methods

Reconstituted HDL
Reconstituted HDL were prepared from apoA-I isolated from human pooled plasma (CSL Behring) [26, 27] and soybean PC (Phospholipon 90, Lipoid AG/Phospholipid GmbH) by the sodium cholate dialysis method as described elsewhere [28, 29] . Reconstituted HDL particles of different size were produced using apoA-I/PL molar ratios of 1:150, 1:100, and 1:50. The conditions for reconstitution were chosen to achieve complete apoA-I and PC incorporation into lipoprotein particles (each formulation contained two apoA-I molecules per particle). After reconstitution of the particles, cholate was removed by dialysis and filtration using Biomax cassettes (NMWR 10 kDa; Millipore). Reconstituted HDL was stored at -70°C in small aliquots or was lyophilized, sealed under vacuum and stored at 4°C. No difference between PCOOHinactivating capacity of frozen vs. lyophilised reconstituted HDL formulations was observed (Supplemental Fig. I ).
Reconstituted HDL containing apoA-I with different levels of oxidation of Met112 residue were prepared using autoxidation of reconstituted HDL (1:50 PC) at 4°C in the dark for various time periods. Met112 is known to be markedly more sensitive to autoxidation as compared to other Met residues of apoA-I [17] . In order to stop oxidation, vials were frozen at -70 °C. After 5, 14, and 31 days of storage, levels of apoA-I oxidized at single Met112 residue were 42%, 64%, and 85%, respectively, as determined by reverse phase HPLC method described elsewhere [16] . LC/MS/MS analysis of reconstituted HDL samples corresponding to the time points of 0, 5 and 31 days of incubation at 4°C was performed as described by Brock et al [30] . Met112 was confirmed to be the primary site of oxidation, whereas other Met residues, Met148 and 86, were oxidized to a lesser degree (Table I, Supplemental). No oxidative modification on aromatic amino acid residues (Phe, Thr and Tyr) of apoA-I followed by protein crosslinking into dimers or higher molecular weight aggregates was detected by LS/MS/MS and SDS PAGE analysis (Supplemental Fig. II, A) . In parallel, small amounts of lipid-free apoA-I were released from rHDL following extensive oxidation of Met112, while the rHDL size was only minimally modified (Supplemental Fig. II, B) . Content of PCOOH in all reconstituted HDL formulations was low and did not exceed 0.114 mol/mol HDL (Table II, Supplemental). Levels of oxidation of apoA-I Met112 were also low and did not exceed 6% (Table I, Supplemental).
Blood samples
Blood samples were withdrawn from the cubital vein of fasting healthy normolipidemic male subjects receiving no medication. EDTA plasma (final EDTA concentration, 1 mg/ml) was prepared from venous blood collected into sterile, evacuated tubes (Vacutainer). Plasma was immediately separated by low-speed centrifugation at 4°C, mixed with sucrose (final concentration, 0.6%) as a cryoprotectant for lipoproteins [31] , aliquoted and frozen at -80°C under nitrogen; each aliquot was thawed only once directly before analyses.
Isolation of lipoproteins and apoA-I
Lipoproteins were isolated from EDTA plasma or from incubation mixtures by single step, isopycnic non-denaturing density gradient ultracentrifugation in a Beckman SW41 Ti rotor at 40,000 rpm for 44 hours in a Beckman XL70 ultracentrifuge at 15°C by a slight modification of the method of Chapman et al. [32] as previously described [33] .
After centrifugation, each gradient was fractionated into 11 fractions corresponding to very low-density lipoprotein (VLDL) + intermediate density lipoprotein (IDL) (d<1.019 g/ml), LDL (5 subfractions, LDL1, d 1.019-1.023 g/ml; LDL2, d 1.023-1.029 g/ml ; LDL3, d 1.029-1.039 g/ml; LDL4, d 1.039-1.050 g/ml, and LDL5, d 1.050-1.063 g/ml) and HDL. Five major HDL subclasses were isolated, i.e., large, light HDL2b (d 1.063-1.087 g/ml) and HDL2a (d 1.088-1.110 g/ml), and small, dense HDL3a (d 1.110-1.129 g/ml), HDL3b (d 1.129-1.154 g/ml) and HDL3c (d 1.154-1.170 g/ml). The validity and reproducibility of this density gradient procedure, which facilitates preparative fractionation of HDL particle subspecies in a non-denaturated, native state, have been extensively documented [32, 34] . Lipoproteins were extensively dialysed against phosphate-buffered saline (PBS; pH 7.4) at 4°C in the dark, stored at 4°C and used within 10 days.
Total LDL fraction was prepared by mixing LDL1, LDL2, LDL3, LDL4 and LDL5 subfractions at their equivalent plasma concentrations. Total HDL fraction was prepared by mixing HDL2b, 2a, 3a, 3b and 3c subfractions at their equivalent plasma concentrations.
Lipid-free apoA-I was isolated from human plasma as described elsewhere [35] .
Chemical analysis of lipoproteins
Total protein, total cholesterol, free cholesterol, PL and triglyceride contents of isolated lipoprotein subfractions were determined using commercially available assays [32, 36] . Cholesteryl ester was calculated by multiplying the difference between total and free cholesterol concentrations by 1.67 [32] . Total lipoprotein mass was calculated as the sum of total protein, cholesteryl ester, free cholesterol, PL and triglyceride and expressed as plasma concentrations (mg/dl). ApoA-I content in HDL was quantitated using a commercially available kit (Diasys, France).
PCOOH inactivating capacity of HDL and apoA-I Met oxidation
Reference LDL obtained from a healthy normolipidemic subject was pre-oxidized at 40 mg total cholesterol/dl with 4 mM of 2,2'-azobis(-amidinopropane) dihydrochloride (AAPH) for 6h at 37°C. Oxidative modification was terminated by addition of EDTA (100 µM) and butylated hydroxytoluene (BHT) (100 µM). Such short oxidation resulted in the accumulation of low amounts of PCOOH (between 5 and 10 mol/mol LDL equivalent to 1-2% of total LDL PC [37] ) and did not cause considerable degradation of LDL as documented by both agarose and acrylamide gel electrophoresis. Agarose gel electrophoresis was performed at the agarose concentration of 1% in 100 mM Tris-Tricine buffer (pH 8.6) for 4 h at 60 V. To run native 6% acrylamide gel electrophoresis, 20 µl of the reaction mixture equivalent to 0.2 µg protein were loaded onto the gel which was run for 10 h at 150 V. All the gels were stained by Coomassie blue. The agarose gel electrophoresis revealed that relative electrophoretic mobility (REM) of LDL at the end of the oxidation equalled 1.47 ± 0.02 (n=4), a value well below the threshold of 3 required for the recognition of oxidized apoB by scavenger receptors [38] . Furthermore, no difference in the electrophoretic mobility of native and oxidized LDL was observed using acrylamide gel electrophoresis, indicative of the absence of the effect of the oxidation on LDL size (data not shown). Finally, agarose gel electrophoresis revealed that addition of EDTA (100 µM) and butylated hydroxytoluene (BHT) (100 µM) at the end of the oxidation fully protected LDL from further oxidative modification as documented by measurements of LDL REM (data not shown).
Oxidized LDL was dialyzed against PBS at 4°C to remove EDTA and excess BHT, and incubated at a concentration of 20 mg total cholesterol/dl in the presence or absence of different concentrations of reconstituted HDL in PBS at 37°C. Since both protein and lipid moieties of HDL are known to determine antioxidative properties of the lipoprotein [18, 20] , HDL particles were compared on the basis of their total mass concentrations. EDTA (100 µM) was present to inhibit lipid peroxidation during the incubation. PCOOH were quantified in the reaction mixture before and after incubation by HPLC with chemiluminescent detection as described elsewhere [18] . PCOOH inactivation by rHDL was defined as PCOOH decrease in oxLDL samples in the presence of rHDL relative to oxLDL alone.
To measure levels of methionine oxidation, reconstituted HDL was subjected to reverse phase HPLC using a C18 column with UV detection at 214 nm as described elsewhere [18] . In brief, this method allows separating and quantifying individual molecular species of oxidized apoA-I with a site-specific oxidation of Met112, Met86, or both [16] . HDL content of non-oxidized apoA-I was assessed in parallel using the same approach. No formation of oxidized species during the sample processing was observed (less than 2% oxidation).
In some experiments, total LDL and total HDL were reisolated from the reaction mixture using density gradient ultracentrifugation as described above and their content of PCOOH was evaluated. In parallel, the content of native and oxidized apoA-I Met residues in reisolated HDL was quantified by HPLC.
Molecular species of PCOOH separated by HPLC were characterised by LC/MS/MS as described elsewhere [20] . Four major species of PCOOH measured using chemiluminiscent detection were identified as, in the order of decreasing abundance, 18:2/16:0, 18:2/18:0, 22:6+20:4/16:0 and 22:6+20:4/18:0 PCOOH.
Cholesterol efflux capacity of HDL
The capacity of the HDL to efflux cellular cholesterol was assessed using [3H]cholesterol-loaded RAW264.7 macrophages [35] . Before initiation of efflux, RAW264.7 cells were loaded with free [15] , HDL particles were compared on the basis of their total protein concentrations. The difference in efflux between stimulated and non-stimulated cells was taken as a measure of ABCA1-mediated efflux. Kinetic parameters of ABCA1-dependent and independent cholesterol efflux mediated by rHDL were determined using the Graph Pad Prism 6 software as described elsewhere [39] .
Statistics
Data are presented as means + standard deviation (SD) unless otherwise indicated. All results were analyzed for statistical significance using one-way ANOVA followed by Dunnet post-hoc test, or using t-test when appropriate. Statistical significance was set at p<0.05.
Results
Reconstituted HDL with an apoA-I/PL ratio of 1:50 efficiently inactivated PC hydroperoxides in pre-oxidized LDL (20 mg total cholesterol/dl equivalent to 0.24 µM) upon their co-incubation at a near-physiologic concentration ratio of 12 mol/mol in vitro at 37°C (Fig. 1) ; in parallel, accumulation of corresponding PC hydroxides was observed (data not shown). PCOOH content of oxidized LDL (oxLDL) incubated alone slowly decreased over time, reflecting PCOOH instability (Fig. 1A) ; such decrease was however significantly more pronounced in the presence of reconstituted HDL. The antioxidative effect of reconstituted HDL was similar for all four PCOOH species assessed, notably 18:2/16:0, 18:2/18:0, 22:6+20:4/16:0 and 22:6+20:4/18:0 PCOOH (data not shown).
The PCOOH inactivation by reconstituted HDL was time-dependent and increased from 12% after 0.5h to 69% after 24h of the incubation (Fig. 1B) . The antioxidative effect of reconstituted HDL levelled off at 15 to 25% between 2 and 6h; subsequent decrease in PCOOH levels after a prolonged incubation of 24h was associated with alterations in reconstituted HDL size and structure and was therefore considered physiologically of a limited importance (data not shown). As a result, incubation time of 4h was selected for subsequent experiments. The effect of reconstituted HDL on oxLDL-derived PCOOH was dose-dependent (Fig. 2) . No hydroperoxide inactivation was detected when the reconstituted HDL was present at a low concentration of 10 mg mass/dl (Fig. 2A) . The PCOOH inactivation however increased to over 20% at higher concentrations of 20 and 40 mg/dl; further elevation of the reconstituted HDL concentration to 80 mg/dl did not enhance the antioxidative effect (Fig. 2B) . The concentration of 20 mg/dl was therefore selected for subsequent experiments. The capacity of reconstituted HDL to inactivate oxLDL-derived PCOOH was evaluated in several reconstituted HDL formulations differing in their chemical composition. First, three reconstituted HDL formulation displaying apoA-I/PC molar ratios of 1:50, 1:100 and 1:150 were compared. We found that the PCOOH-inactivating capacity of such particles decreased with decreasing apoA-I/PC ratio (Fig. 3A) . Interestingly, on an HDL mass basis, the absolute activity was markedly lower than that displayed by plasma HDL3 isolated from a healthy normolipidemic donor (Fig. 3A) . Since HDL3 isolated by our density gradient ultracentrifugation approach displays both PON1 and PAF-AH activities [36] , they can contribute to the enhanced capacity of HDL3 to inactivate PCOOH relative to rHDL.
Replotting the data on the basis of apoA-I content rather than total mass reveals that the capacity of reconstituted HDLs to inactivate PCOOH was directly proportional to the apoA-I concentration in the reaction mixtures (Fig. 3B) . By contrast, the relationship between PCOOHinactivating capacity of rHDL and its PC content tended to inverse (Fig. 3C) . Interestingly, lipidfree apoA-I isolated from human plasma did not reveal PCOOH-inactivating activity in this assay (6.5 ±3.9% of inactivated PCOOH at 8 mg apoA-I/dl; n=3). Similarly, PCOOH inactivation by plasma-derived HDL was not enhanced by the plasma pre-incubation with lipid-free apoA-I (Table III Supplemental Having established the dependence of PCOOH inactivation on apoA-I content, we next asked about the effect of apoA-I with oxidized methionine residues. Reconstituted HDL particles of a fixed apoA-I/PC molar ratio of 1:50 but differing in the level of oxidation of Met112 residue of apoA-I from 6 to 85% were prepared by controlled oxidation. We observed that such approach gradually decreased PCOOH-inactivating capacity of reconstituted HDL (Fig. 4) . Extensive (85%) oxidation of Met112 in apoA-I resulted in the complete loss of the PCOOH-inactivating capacity (Fig. 4A) . As a consequence, the capacity of reconstituted HDLs containing the oxidized Met residue to inactivate PCOOH was directly proportional to the concentration of non-oxidized apoA-I in the reaction mixtures (Fig. 4B) . In order to verify that reconstituted HDLs were capable of decreasing PCOOH content of pre-oxidized LDL, we re-isolated LDL from the reaction mixture following its incubation with reconstituted HDL. We observed that first, reconstituted HDL (1:50 PC) decreased PCOOH content of re-isolated LDL by 39% (Fig. 5) . This effect was similar for all molecular species of PCOOH (data not shown). Second, extensive oxidation of apoA-I Met112 in reconstituted HDL resulted in the complete loss of the capacity of reconstituted HDL to inactivate PCOOH in reisolated LDL (Fig. 5) . The results obtained in re-isolated LDL were therefore similar to those obtained in reconstituted HDL and LDL mixtures (Fig. 4) . The antioxidative effects measured in the reaction mixture were however consistently lower relative to those observed in re-isolated LDL (Fig. 5) . In parallel with the decrease in PCOOH content of LDL, PCOOH content of re-isolated HDL increased (Fig. 5) . Initial content of PCOOH in all reconstituted HDL formulations was low (Table II , Supplemental) and did not significantly contribute to the levels measured following incubations with oxLDL. The accumulation of PCOOH in reconstituted HDL was enhanced by apoA-I Met112 oxidation (Fig. 5) . The relative distribution of PCOOH between LDL and reconstituted HDL did not however depend on the level of Met112 oxidation (Supplement Fig. III) . Indeed, LDL re-isolated from the reaction mixtures contained about two-thirds of the total PCOOH independently of the oxidation level of Met112 in reconstituted HDL, while re-isolated HDL carried the remainder.
Incubation of reconstituted HDL with oxLDL resulted in further oxidation of apoA-I Met residues (Fig. 6) . The content of non-oxidized apoA-I in the reconstituted HDL (1:50 PC) decreased after the incubation, whereas that of oxidized apoA-I species increased (Fig. 6A) . There was no apparent specificity in the accumulation of individual molecular species of oxidized apoA-I with a site-specific oxidation of Met112, Met86 or both (Fig. 6A) . Similar results were obtained using HDL reconstituted with different amounts of PC at the apoA-I/PC molar ratios of 1:100 (data not shown) and 1:150 (Fig. 6B) .
In these studies, we noted that low amounts of oxidized methionines accumulated in apoA-I during incubation in the absence of oxLDL. This autoxidation was lowest in native HDL (~6%) and highest in reconstituted HDL with the highest PL content (up to 40%). As a consequence, the oxidation of Met residues in apoA-I upon incubation with oxLDL (i.e. difference between HDL content of non-oxidized apoA-I before and after the incubation) was less pronounced in rHDL with a higher lipid content (cf. Fig. 6A and 6B) . Thus, Met residues of apoA-I in the apoA-I/1:50 PC and 1:150 PC particles were oxidized by 55.0 ±4.9 and 41.7±5.8 %, respectively, during the incubation in the presence of oxLDL (n=5). ApoA-I Met residues of native HDL3 were more sensitive to the exposure to oxLDL, with the total increase in oxidized Met of 71.6 ±0.4 % of total apoA-I at the end of the incubation (n=4). Interestingly, Met residues of lipidfree apoA-I were only weakly sensitive to the exposure to oxLDL, with the total content of oxidized Met increasing from 15.8 (15.8-15.9) to 22.2 (21.8-22.6) % of total apoA-I at the end of the incubation (n=2). As expected, controlled autoxidation of reconstituted HDL resulted in an accumulation of apoA-I species containing oxidized Met residues and in a decrease in non-oxidized apoA-I (Fig.  7) . As a consequence, oxidation of Met residues in apoA-I upon incubation with oxLDL (difference between HDL content of non-oxidized apoA-I before and after the incubation) decreased with increasing initial Met112(O) content in reconstituted HDL (Fig. 7A) . Similarly, differences between HDL content of oxidized apoA-I Met before and after the incubation diminished with increasing baseline Met oxidation (Fig. 7B) . As a consequence, PCOOH inactivation by reconstituted HDL formulations was proportional to consumption of apoA-I Met upon incubation with oxLDL (Fig. 7C) . We next determined the effect of reconstituted HDL with different chemical composition and different states of methionine oxidation on cellular cholesterol efflux. The capacity of reconstituted HDL to efflux [3H]-cholesterol from lipid-loaded RAW264.7 macrophages via ABCA1 increased with increasing apoA-I/PC ratio (Fig. 8A) . On the other hand, ABCA1-independent cholesterol efflux was inversely related to the apoA-I/PC ratio in reconstituted HDL (Fig. 8B) . Consistent with these data, Vmax values calculated for ABCA1-dependent efflux were 2.1-fold higher for HDL 1:50 relative to HDL 1:150 (Table IV Supplemental) . By contrast, Vmax values calculated for ABCA1-independent efflux were 1.7-fold lower for HDL 1:50 relative to HDL 1:150. In parallel, relative catalytic efficiency of ABCA1-dependent efflux increased while that of ABCA1-independent efflux decreased with increasing apoA-I/PC ratio (Table IV Supplemental). Finally, controlled oxidation of apoA-I Met112 increased ABCA1-mediated cholesterol efflux from RAW164.7 cells but did not affect ABCA1-independent efflux (Fig. 9 ). rHDL protein, µg/ml rHDL protein, µg/ml
Discussion
Our studies of structure-function relationships in reconstituted HDL particles focussed on the antioxidative activity and cellular cholesterol efflux capacity of HDL, both known to belong to the major anti-atherogenic properties of the lipoprotein [9, 13, 14] . We evaluated inactivation of PCOOH in mildly oxLDL and efflux of cholesterol from lipid-loaded macrophages as two metrics of HDL function. In terms of the structure and composition of HDL, we studied reconstituted HDL containing only apoA-I and PC as two essential components and varied the apoA-I content of the particle relative to PL as well as the level of apoA-I oxidation. Our data revealed that the capacity to both inactivate oxLDL-derived PCOOH and efflux cellular cholesterol via ABCA1 increased with increasing apoA-I content in reconstituted HDL. In contrast, controlled oxidation of Met112 residue of apoA-I decreased PCOOH inactivation but increased cholesterol efflux.
HDL is well established to protect LDL from oxidative stress induced by one-electron oxidants, such as free radicals [13, 40, 41] , resulting in the inhibition of the production of proinflammatory oxidized lipids, including LOOH and short-chain oxidized PLs. On the other hand, HDL is unlikely to protect LDL from oxidation induced by two-electron oxidants, such as hypochlorite and peroxynitrite, which directly attack proteins and only weakly modify lipid moieties [42] . Mechanisms of the HDL-mediated inactivation of LOOH involve initial transfer of PLOOH from oxLDL to HDL with subsequent reduction of PLOOH by redox-active Met residues of apoA-I, which results in the formation of PL hydroxides (PLOH) and methionine sulfoxides [9, 36] . By contrast, hydrolytic inactivation of short-chain oxidized PL by HDL is primarily derived from the action of HDL-associated enzymes, such as paraoxonase 1 and platelet activating factor acetyl hydrolase (PAF-AH) [13, 40] . In addition to the inactivation of lipid hydroperoxides, apoA-I equally provides a key contribution to the capacity of HDL to efflux cholesterol from lipidloaded macrophages [15] . This process is predominantly mediated by ABCA1 which is overexpressed on the cell surface upon lipid loading [43] .
HDL particles are however highly heterogeneous in their composition, metabolism and function [44] . Indeed, small, dense, protein-rich HDL3 provide more efficient protection of LDL from oxidative stress and display higher cholesterol efflux capacity from lipid-loaded macrophages as compared to large, light, lipid-rich HDL2 [20] . Native HDLs are however characterised by a complex composition, rendering a clear-cut conclusion on the links between the function and protein-to-lipid ratio in HDL not straightforward. It is important in this regard that our present structure-function analysis using model HDL particles of simplified composition confirms the direct relationship of the protein-to-lipid ratio with two major metrics of HDL function, and notably with the antioxidative and cholesterol effluxing activities. As a corollary, the both metrics were directly associated with HDL density and inversely associated with HDL size, as already observed in native plasma HDL [20] .
The increase in the anti-atherogenic activities of HDL at higher protein-to-lipid ratios can be most straightforwardly accounted for by the elevated particle content of apoA-I, the major functional HDL component. This conclusion is consistent with data on PCOOH inactivation obtained at a fixed total HDL mass. In a similar fashion, our earlier data revealed that reconstituted HDL particles displaying elevated protein-to-lipid ratios showed enhanced capacity to efflux cholesterol from macrophages when compared on a total mass basis [15] . By contrast, our present data demonstrate that protein-rich reconstituted HDL containing only apoA-I and PC was a more efficient acceptor of cellular cholesterol relative to their lipid-rich counterparts when compared on a total protein basis. These data indicate that, other than apoA-I content, HDL characteristics contribute to the potent cholesterol-effluxing properties of small, lipid-rich particles. Data on the immunoreactivity of HDL subpopulations towards a set of anti-apoA-I antibodies recognizing distinct epitopes of the protein suggest that apoA-I conformation can be modulated by HDL lipid content, resulting in enhanced interaction with ABCA1 of lipid-poor subspecies [15, 45] . As a consequence, differential conformational modulation of apoA-I might result in an improved accessibility of redox-active Met residues for the interaction with oxLDL-derived PCOOH molecules and hence enhanced PCOOH inactivation in small, protein-rich HDL.
Interestingly, lipid-free apoA-I isolated from human plasma revealed only a weak capacity to inactivate oxLDL-derived PCOOH, indicating that some lipidation is required for the antioxidative activity of the protein. This finding may reflect the essential role of the surface PL monolayer for the efficient transfer of PLOOH to apoA-I/lipid complexes with subsequent redox inactivation.
Consistent with the key role of redox-active Met residues for the lipid hydroperoxideinactivating capacity of HDL, gradual oxidation of Met112 resulted in a decrease in this activity with complete loss at an elevated degree of oxidation. Interestingly, such oxidation differentially affected HDL-mediated cholesterol efflux from macrophages, which increased in parallel with the accumulation of Met112(O). This observation can be accounted for by elevated conformational lability of apoA-I upon mild HDL oxidation [46, 47] , similar to that employed in our study to progressively oxidize Met112. In addition, apoA-I association with lipids is attenuated by mild oxidation secondary to the addition of oxygen atoms to the protein structure [40, 48] . Consistent with these findings, we detected small amounts of lipid-free apoA-I in rHDL formulations with a high content of Met112(O) (Supplemental Fig. II) . Importantly, lipid-free apoA-I represents an excellent acceptor of cellular cholesterol via ABCA1 [15] . Acting together, elevated conformational lability and diminished lipid affinity of mildly oxidized apoA-I can be expected to enhance release of the protein from HDL and its exchange between HDL particles and the ABCA1 transporter, facilitating cholesterol efflux from cells.
Reconstituted HDL formulations are currently in clinical trials for the treatment of cardiovascular disease [5] . We have previously shown that one such formulation, CSL112 [49] , elevated plasma cholesterol efflux capacity in both healthy volunteers [50] and patients with atherothrombotic disease [51] . The results presented here suggest that CSL112 may also enhance antioxidative activity of the plasma HDL pool, providing another potential benefit. In recent in vivo studies, we found that parent CSL112 particles were extensively remodelled post infusion, yielding both larger and smaller daughter species [52] . Studies of purified products of such remodeling revealed that species of small and intermediate size displayed both strong cholesterol efflux capacity and antioxidative activity, while lipid-poor apoA-I possessed strong cholesterol efflux capacity but weak antioxidative activity [52] . These findings are fully consistent with our present data, emphasizing both the broad spectrum of structural forms in which apoA-I may circulate and the critical role of their structure in determining HDL function.
Our studies were not free of limitations, which primarily involved use of HDL particles in the absence of other relevant components of plasma, especially albumin, which can modulate the effects of rHDL. Despite this, our structure-function analysis of reconstituted HDL highlights important considerations for the design of future HDL therapeutics. Available data suggest that deficient HDL-mediated protection of LDL from oxidative stress and defective cellular cholesterol efflux capacity can both contribute to accelerated atherogenesis [53, 54] . As a corollary, normalization of the atheroprotective properties of HDL possesses the potential to diminish oxidative modification of LDL in the arterial intima and to accelerate cholesterol removal from macrophages, thereby inducing plaque stabilization and/or regression and attenuating disease development. Small, dense reconstituted HDL particles enriched in apoA-I relative to PC represent a primary therapeutic option to be developed in this regard.
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